Background: The management of delayed gastrointestinal recovery after surgery is an unmet challenge. Uncertainty over its pathophysiology has limited previous research, but recent evidence identifies intestinal inflammation and activation of mu-opioid receptors as key mechanisms. Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended by enhanced recovery protocols for their opioid-sparing and anti-inflammatory properties. Objectives: To explore the safety and efficacy of NSAIDs to improve gastrointestinal recovery and to identify opportunities for future research. Data Sources: MEDLINE, EMBASE and the Cochrane Library were systematically searched from inception up to January 2018 Study Selection: Randomized controlled trials (RCTs) assessing the effect of NSAIDs on gastrointestinal recovery after elective colorectal surgery were eligible. Main Outcomes: Measures of postoperative gastrointestinal recovery, including first passage of flatus, stool, and oral tolerance. Results: Six RCTs involving 563 participants were identified. All participants received patientcontrolled morphine and either NSAID (non-selective: n=4; cyclooxygenase-2-selective: n=1; either: n=1) or placebo. Patients receiving NSAID had faster return of flatus (mean difference: